These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31849943)

  • 1. Elucidating the Immune Evasion Mechanisms of
    Walter L; Sürth V; Röttgerding F; Zipfel PF; Fritz-Wolf K; Kraiczy P
    Front Immunol; 2019; 10():2722. PubMed ID: 31849943
    [No Abstract]   [Full Text] [Related]  

  • 2. Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1.
    Herzberger P; Siegel C; Skerka C; Fingerle V; Schulte-Spechtel U; van Dam A; Wilske B; Brade V; Zipfel PF; Wallich R; Kraiczy P
    Infect Immun; 2007 Oct; 75(10):4817-25. PubMed ID: 17635869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.
    Hammerschmidt C; Koenigs A; Siegel C; Hallström T; Skerka C; Wallich R; Zipfel PF; Kraiczy P
    Infect Immun; 2014 Jan; 82(1):380-92. PubMed ID: 24191298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic factor H-binding activity of CspA protects Lyme borreliae from the host complement in feeding ticks to facilitate tick-to-host transmission.
    Hart T; Nguyen NTT; Nowak NA; Zhang F; Linhardt RJ; Diuk-Wasser M; Ram S; Kraiczy P; Lin YP
    PLoS Pathog; 2018 May; 14(5):e1007106. PubMed ID: 29813137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete.
    Kenedy MR; Akins DR
    Infect Immun; 2011 Apr; 79(4):1451-7. PubMed ID: 21282413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi.
    Kenedy MR; Vuppala SR; Siegel C; Kraiczy P; Akins DR
    Infect Immun; 2009 Jul; 77(7):2773-82. PubMed ID: 19451251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation.
    Alitalo A; Meri T; Rämö L; Jokiranta TS; Heikkilä T; Seppälä IJ; Oksi J; Viljanen M; Meri S
    Infect Immun; 2001 Jun; 69(6):3685-91. PubMed ID: 11349031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement resistance of Borrelia burgdorferi correlates with the expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins.
    Kraiczy P; Hellwage J; Skerka C; Becker H; Kirschfink M; Simon MM; Brade V; Zipfel PF; Wallich R
    J Biol Chem; 2004 Jan; 279(4):2421-9. PubMed ID: 14607842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components.
    Schwab J; Hammerschmidt C; Richter D; Skerka C; Matuschka FR; Wallich R; Zipfel PF; Kraiczy P
    PLoS One; 2013; 8(1):e53659. PubMed ID: 23320099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle.
    Lin YP; Frye AM; Nowak TA; Kraiczy P
    Front Cell Infect Microbiol; 2020; 10():1. PubMed ID: 32083019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterisation of Complement Regulator Acquiring Surface Protein-1 of serum resistant Borrelia garinii OspA serotype 4.
    van Burgel ND; Kraiczy P; Schuijt TJ; Zipfel PF; van Dam AP
    BMC Microbiol; 2010 Feb; 10():43. PubMed ID: 20146822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement evasion strategies of Borrelia burgdorferi sensu lato.
    Dulipati V; Meri S; Panelius J
    FEBS Lett; 2020 Aug; 594(16):2645-2656. PubMed ID: 32748966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterization of complement regulator-acquiring surface proteins of Borrelia burgdorferi.
    Kraiczy P; Skerka C; Brade V; Zipfel PF
    Infect Immun; 2001 Dec; 69(12):7800-9. PubMed ID: 11705962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CspA from Borrelia burgdorferi inhibits the terminal complement pathway.
    Hallström T; Siegel C; Mörgelin M; Kraiczy P; Skerka C; Zipfel PF
    mBio; 2013 Aug; 4(4):. PubMed ID: 23943762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi.
    Hammerschmidt C; Hallström T; Skerka C; Wallich R; Stevenson B; Zipfel PF; Kraiczy P
    Clin Dev Immunol; 2012; 2012():349657. PubMed ID: 22400034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. nov.
    Herzberger P; Siegel C; Skerka C; Fingerle V; Schulte-Spechtel U; Wilske B; Brade V; Zipfel PF; Wallich R; Kraiczy P
    Int J Med Microbiol; 2009 Feb; 299(2):141-54. PubMed ID: 18706858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional characterization of complement regulator-acquiring surface protein 1 of the Lyme disease spirochetes Borrelia afzelii and Borrelia garinii.
    Wallich R; Pattathu J; Kitiratschky V; Brenner C; Zipfel PF; Brade V; Simon MM; Kraiczy P
    Infect Immun; 2005 Apr; 73(4):2351-9. PubMed ID: 15784581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.
    Röttgerding F; Wagemakers A; Koetsveld J; Fingerle V; Kirschfink M; Hovius JW; Zipfel PF; Wallich R; Kraiczy P
    Sci Rep; 2017 Mar; 7(1):303. PubMed ID: 28331202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of human complement regulators FHL-1 and factor H to CRASP-1 orthologs of Borrelia burgdorferi.
    Kraiczy P; Rossmann E; Brade V; Simon MM; Skerka C; Zipfel PF; Wallich R
    Wien Klin Wochenschr; 2006 Nov; 118(21-22):669-76. PubMed ID: 17160605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.